SCRN3
gene geneOn this page
Also known as FLJ23142
Summary
SCRN3 (secernin 3, HGNC:30382) is a protein-coding gene on chromosome 2q31.1, encoding Secernin-3 (Q0VDG4). Plays a role in thermal nociception.
Predicted to enable cysteine-type exopeptidase activity and dipeptidase activity. Predicted to be involved in detection of temperature stimulus involved in sensory perception of pain.
Source: NCBI Gene 79634 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total
- Druggable target: yes
- MANE Select transcript:
NM_024583
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30382 |
| Approved symbol | SCRN3 |
| Name | secernin 3 |
| Location | 2q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ23142 |
| Ensembl gene | ENSG00000144306 |
| Ensembl biotype | protein_coding |
| OMIM | 614967 |
| Entrez | 79634 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 18 protein_coding, 5 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay
ENST00000272732, ENST00000409673, ENST00000424069, ENST00000427038, ENST00000435964, ENST00000437944, ENST00000458563, ENST00000475928, ENST00000488349, ENST00000490927, ENST00000548031, ENST00000548868, ENST00000548921, ENST00000549848, ENST00000877601, ENST00000877602, ENST00000877603, ENST00000877604, ENST00000877605, ENST00000877606, ENST00000877607, ENST00000877608, ENST00000968051, ENST00000968052, ENST00000968053
RefSeq mRNA: 11 — MANE Select: NM_024583
NM_001193528, NM_001412202, NM_001412203, NM_001412204, NM_001412205, NM_001412206, NM_001412207, NM_001412208, NM_001412209, NM_001412210, NM_024583
CCDS: CCDS2258, CCDS54420
Canonical transcript exons
ENST00000272732 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001016386 | 174398275 | 174398442 |
| ENSE00001710210 | 174395730 | 174395817 |
| ENSE00002362279 | 174427713 | 174429575 |
| ENSE00003463596 | 174424475 | 174424649 |
| ENSE00003488885 | 174404103 | 174404315 |
| ENSE00003670993 | 174400990 | 174401189 |
| ENSE00003678766 | 174422885 | 174423047 |
| ENSE00003784643 | 174399922 | 174400103 |
Expression profiles
Bgee: expression breadth ubiquitous, 267 present calls, max score 91.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 15.3139 / max 332.3969, expressed in 1780 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 23792 | 13.9174 | 1757 |
| 23793 | 0.7657 | 403 |
| 23794 | 0.6309 | 370 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortical plate | UBERON:0005343 | 91.35 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.93 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.73 | gold quality |
| ventricular zone | UBERON:0003053 | 90.24 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 89.69 | gold quality |
| spinal cord | UBERON:0002240 | 89.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 89.24 | gold quality |
| adrenal tissue | UBERON:0018303 | 89.12 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.06 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 88.66 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.51 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.37 | gold quality |
| jejunal mucosa | UBERON:0000399 | 88.29 | gold quality |
| rectum | UBERON:0001052 | 87.69 | gold quality |
| muscle of leg | UBERON:0001383 | 87.62 | gold quality |
| oral cavity | UBERON:0000167 | 87.42 | gold quality |
| monocyte | CL:0000576 | 87.32 | gold quality |
| gastrocnemius | UBERON:0001388 | 87.22 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 87.12 | gold quality |
| mononuclear cell | CL:0000842 | 86.98 | gold quality |
| cingulate cortex | UBERON:0003027 | 86.98 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.76 | gold quality |
| right adrenal gland | UBERON:0001233 | 86.70 | gold quality |
| amygdala | UBERON:0001876 | 86.60 | gold quality |
| biceps brachii | UBERON:0001507 | 86.57 | gold quality |
| leukocyte | CL:0000738 | 86.52 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 86.25 | gold quality |
| jejunum | UBERON:0002115 | 86.19 | gold quality |
| tonsil | UBERON:0002372 | 86.18 | gold quality |
| eye | UBERON:0000970 | 86.17 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.55 |
| E-MTAB-6075 | no | 1552.17 |
| E-GEOD-99795 | no | 70.91 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
86 targeting SCRN3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-4255 | 99.72 | 67.70 | 1541 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | scrn3 | ENSDARG00000016611 |
| mus_musculus | Scrn3 | ENSMUSG00000008226 |
| rattus_norvegicus | Scrn3 | ENSRNOG00000018657 |
| drosophila_melanogaster | CG10098 | FBGN0037472 |
Paralogs (2): SCRN1 (ENSG00000136193), SCRN2 (ENSG00000141295)
Protein
Protein identifiers
Secernin-3 — Q0VDG4 (reviewed: Q0VDG4)
All UniProt accessions (7): Q0VDG4, A0A1D5RMN9, C9JID8, C9JNS3, F8W0M9, F8WBX0, H9KVC8
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in thermal nociception.
Similarity. Belongs to the peptidase C69 family. Secernin subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q0VDG4-1 | 1 | yes |
| Q0VDG4-2 | 2 |
RefSeq proteins (11): NP_001180457, NP_001399131, NP_001399132, NP_001399133, NP_001399134, NP_001399135, NP_001399136, NP_001399137, NP_001399138, NP_001399139, NP_078859* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005322 | Peptidase_C69 | Family |
Pfam: PF03577
UniProt features (10 total): sequence variant 3, modified residue 2, propeptide 1, chain 1, active site 1, splice variant 1, mutagenesis site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q0VDG4-F1 | 91.96 | 0.81 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 6
Post-translational modifications (2): 6, 6
Mutagenesis-validated functional residues (1):
| Position | Phenotype |
|---|---|
| 2–5 | does not affect glyoxylate or pyruvate formation. |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 115 (showing top):
FREAC2_01, GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS, GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, IVANOVA_HEMATOPOIESIS_MATURE_CELL, FOXO1_01, GOBP_SENSORY_PERCEPTION_OF_PAIN, GOBP_DETECTION_OF_TEMPERATURE_STIMULUS, FREAC3_01, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_ABIOTIC_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, FOXO4_02
GO Biological Process (2): proteolysis (GO:0006508), detection of temperature stimulus involved in sensory perception of pain (GO:0050965)
GO Molecular Function (2): dipeptidase activity (GO:0016805), cysteine-type exopeptidase activity (GO:0070004)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| exopeptidase activity | 2 |
| protein metabolic process | 1 |
| sensory perception of pain | 1 |
| detection of temperature stimulus involved in sensory perception | 1 |
| cysteine-type peptidase activity | 1 |
Protein interactions and networks
STRING
578 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCRN3 | ZNF639 | Q9UID6 | 414 |
| SCRN3 | ZNF227 | Q86WZ6 | 398 |
| SCRN3 | ASB8 | Q9H765 | 397 |
| SCRN3 | ALKBH1 | Q13686 | 394 |
| SCRN3 | ADO | Q96SZ5 | 381 |
| SCRN3 | HBM | Q6B0K9 | 377 |
| SCRN3 | CCDC82 | Q8N4S0 | 375 |
| SCRN3 | ERGIC2 | Q96RQ1 | 372 |
| SCRN3 | ITPRIPL2 | Q3MIP1 | 370 |
| SCRN3 | DNAJC16 | Q9Y2G8 | 366 |
| SCRN3 | MITD1 | Q8WV92 | 356 |
| SCRN3 | SIPA1L3 | O60292 | 342 |
| SCRN3 | ST8SIA3 | O43173 | 342 |
| SCRN3 | RHBG | Q9H310 | 339 |
| SCRN3 | FAM76B | Q5HYJ3 | 336 |
IntAct
16 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGOH | CASC3 | psi-mi:“MI:0914”(association) | 0.970 |
| SMYD1 | ADSS2 | psi-mi:“MI:0914”(association) | 0.780 |
| DYDC2 | INPPL1 | psi-mi:“MI:0914”(association) | 0.560 |
| RCVRN | RAB9A | psi-mi:“MI:0914”(association) | 0.530 |
| SCRN3 | DAPK1 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| SCRN3 | EPS8 | psi-mi:“MI:0915”(physical association) | 0.440 |
| EPS8 | SCRN3 | psi-mi:“MI:0403”(colocalization) | 0.440 |
| SPATA20 | SCRN3 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPK1 | SPAG9 | psi-mi:“MI:0914”(association) | 0.350 |
| PID1 | LRPAP1 | psi-mi:“MI:0914”(association) | 0.350 |
| SPATA20 | HDAC4 | psi-mi:“MI:0914”(association) | 0.350 |
| SCRN3 | OXSR1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (27): SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Reconstituted Complex), SCRN3 (Affinity Capture-RNA), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), SCRN3 (Affinity Capture-MS), OXSR1 (Affinity Capture-MS)
ESM2 similar proteins: A2VD33, A7SLW1, A9RBS1, B4G0F3, B8BKI7, C6JS30, E0CTF3, F4IV16, K7QHS5, K7QKH1, O00116, O15382, O22494, O23617, O23732, O35854, O35855, O80738, P0C7R2, P24288, P46416, P54687, P54688, P54690, P97275, Q06429, Q0VDG4, Q0WUI9, Q28C69, Q3T056, Q5EA40, Q5R979, Q5REP0, Q6PCE3, Q8C0I1, Q8L7M0, Q93Y32, Q948J9, Q94AH8, Q9FIV6
Diamond homologs: P83939, Q0V984, Q0VDG4, Q12765, Q17QS0, Q3TMH2, Q5TYS5, Q5XH17, Q6AY84, Q6AYR8, Q803W1, Q8VCA8, Q96FV2, Q9CZC8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 52 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1270 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:174398273:A:AG | acceptor_gain | 1.0000 |
| 2:174398274:G:GG | acceptor_gain | 1.0000 |
| 2:174398301:T:TA | acceptor_gain | 1.0000 |
| 2:174398438:TTAAG:T | donor_loss | 1.0000 |
| 2:174398439:TAAG:T | donor_loss | 1.0000 |
| 2:174398443:G:A | donor_loss | 1.0000 |
| 2:174398444:T:G | donor_loss | 1.0000 |
| 2:174399919:CA:C | acceptor_loss | 1.0000 |
| 2:174399920:A:AG | acceptor_gain | 1.0000 |
| 2:174399920:AGT:A | acceptor_gain | 1.0000 |
| 2:174399921:G:GA | acceptor_gain | 1.0000 |
| 2:174399921:GT:G | acceptor_gain | 1.0000 |
| 2:174399921:GTG:G | acceptor_gain | 1.0000 |
| 2:174399921:GTGT:G | acceptor_gain | 1.0000 |
| 2:174399921:GTGTA:G | acceptor_gain | 1.0000 |
| 2:174400075:G:GT | donor_gain | 1.0000 |
| 2:174400088:G:GT | donor_gain | 1.0000 |
| 2:174400089:A:T | donor_gain | 1.0000 |
| 2:174400099:GTCAG:G | donor_loss | 1.0000 |
| 2:174400100:TCAG:T | donor_loss | 1.0000 |
| 2:174400101:CAGGT:C | donor_loss | 1.0000 |
| 2:174400102:AGGTT:A | donor_loss | 1.0000 |
| 2:174400988:A:AG | acceptor_gain | 1.0000 |
| 2:174400989:G:GG | acceptor_gain | 1.0000 |
| 2:174400989:GACTT:G | acceptor_gain | 1.0000 |
| 2:174401161:G:T | donor_gain | 1.0000 |
| 2:174401187:AAGGT:A | donor_loss | 1.0000 |
| 2:174401188:AGGT:A | donor_loss | 1.0000 |
| 2:174401190:GT:G | donor_loss | 1.0000 |
| 2:174401191:T:G | donor_loss | 1.0000 |
AlphaMissense
2821 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:174398357:A:T | K25I | 0.999 |
| 2:174398358:A:C | K25N | 0.997 |
| 2:174398358:A:T | K25N | 0.997 |
| 2:174422971:A:C | S281R | 0.997 |
| 2:174422973:C:A | S281R | 0.997 |
| 2:174422973:C:G | S281R | 0.997 |
| 2:174398361:T:A | N26K | 0.996 |
| 2:174398361:T:G | N26K | 0.996 |
| 2:174398357:A:C | K25T | 0.995 |
| 2:174398354:G:A | G24E | 0.994 |
| 2:174399973:A:C | S71R | 0.994 |
| 2:174399975:T:A | S71R | 0.994 |
| 2:174399975:T:G | S71R | 0.994 |
| 2:174400998:T:C | L117P | 0.994 |
| 2:174398356:A:G | K25E | 0.993 |
| 2:174422921:G:C | R264P | 0.993 |
| 2:174399994:G:A | G78R | 0.992 |
| 2:174399994:G:C | G78R | 0.992 |
| 2:174399994:G:T | G78W | 0.992 |
| 2:174400009:G:C | A83P | 0.992 |
| 2:174400990:A:C | R114S | 0.992 |
| 2:174400990:A:T | R114S | 0.992 |
| 2:174400093:G:C | D111H | 0.991 |
| 2:174422980:T:C | S284P | 0.991 |
| 2:174398356:A:C | K25Q | 0.990 |
| 2:174399997:G:C | A79P | 0.990 |
| 2:174400006:G:A | G82R | 0.990 |
| 2:174400006:G:C | G82R | 0.990 |
| 2:174400025:T:A | V88D | 0.990 |
| 2:174400033:G:T | G91W | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000053905 (2:174396494 G>A,T), RS1000065902 (2:174421665 A>G), RS1000169259 (2:174400618 G>A), RS1000289039 (2:174402799 C>A), RS1000387836 (2:174395386 C>A), RS1000536436 (2:174414599 A>G), RS1000612020 (2:174400805 C>T), RS1000624054 (2:174410030 G>A), RS1000676112 (2:174410290 T>G), RS1000680131 (2:174402539 T>C), RS1000979648 (2:174421102 A>G), RS1001067100 (2:174423296 A>G), RS1001117208 (2:174413239 C>G,T), RS1001128550 (2:174413858 T>A), RS1001266047 (2:174394982 G>A)
Disease associations
OMIM: gene MIM:614967 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007953_11 | Glycated hemoglobin levels | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004541 | HbA1c measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6196085 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.70 | IC50 | 200 | nM | CHEMBL6172043 |
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Acetaminophen | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| geldanamycin | increases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| beta-lapachone | decreases expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| pentanal | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Gallic Acid | decreases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Testosterone | decreases expression | 1 |
| Thimerosal | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL6136116 | Binding | Inhibition of full length human SCRN3 transfected in HEK293T cells | Classifying covalent protein binders by their targeted binding site. — Bioorg Med Chem Lett |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.